Global AI in Precision Medicine Market is Expected to Showcase a Significant Growth at a Massive CAGR of ~33% by 2032
The AI in precision medicine market is experiencing significant growth, driven by the increasing global prevalence of chronic and genetic disorders, which has heightened the demand for personalized treatment approaches. This growth is further supported by the increasing demand for precision diagnostics and customized therapies that leverage AI's capabilities in analyzing complex biological data. Advancements in AI-driven technologies, along with ongoing innovation in product development, are improving the accuracy and efficiency of precision-based interventions.
New York, USA, May 28, 2025 (GLOBE NEWSWIRE) -- Global AI in Precision Medicine Market is Expected to Showcase a Significant Growth at a Massive CAGR of ~33% by 2032 | DelveInsight
The AI in precision medicine market is experiencing significant growth, driven by the increasing global prevalence of chronic and genetic disorders, which has heightened the demand for personalized treatment approaches. This growth is further supported by the increasing demand for precision diagnostics and customized therapies that leverage AI's capabilities in analyzing complex biological data. Advancements in AI-driven technologies, along with ongoing innovation in product development, are improving the accuracy and efficiency of precision-based interventions.
DelveInsight's AI in Precision Medicine Market Insights report provides the current and forecast market analysis, individual leading AI in precision medicine companies' market shares, challenges, AI in precision medicine market drivers, barriers, trends, and key market AI in precision medicine companies in the market.
Key Takeaways from the AI in Precision Medicine Market Report
As per DelveInsight estimates, North America is anticipated to dominate the global AI in precision medicine market during the forecast period.
In the product segment of the AI in precision medicine market, the hardware/software category held the largest revenue share in 2024.
Notable AI in precision medicine companies such as TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., and several others are currently operating in the AI in precision medicine market.
In April 2025, Illumina Inc. and Tempus AI, Inc. partnered to accelerate the clinical adoption of next-generation sequencing tests. By combining Illumina's advanced AI technologies with Tempus's extensive multimodal data platform, the collaboration aims to train genomic algorithms and speed up the use of molecular testing in patient care.
In February 2025, Ibex Medical Analytics received FDA 510(k) clearance for Ibex Prostate Detect, an in vitro diagnostic device that uses AI to generate heatmaps to identify small or rare prostatic cancers.
In June 2024, Avicenna.AI, a leading medical imaging AI company, received 510(k) clearance from the FDA for CINA-VCF, an AI-powered triage and notification tool designed to detect unsuspected vertebral compression fractures (VCFs) in patients undergoing chest or abdomen CT scans.
In March 2024, Bayer and Aignostics entered into a collaboration to advance next-generation precision oncology. Together, they will co-develop a novel target identification platform that utilizes multimodal patient data and cutting-edge AI/ML algorithms to enhance cancer treatment precision.
To read more about the latest highlights related to the AI in precision medicine market, get a snapshot of the key highlights entailed in the Global AI in Precision Medicine Market Report
AI in Precision Medicine Overview
Artificial intelligence (AI) is revolutionizing precision medicine by enabling highly personalized approaches to disease diagnosis, treatment, and prevention. By analyzing vast datasets from genomic sequencing, electronic health records, imaging, and wearable devices, AI algorithms can uncover patterns and biomarkers that are often invisible to human researchers. These insights allow clinicians to identify specific disease subtypes, predict individual patient responses to therapies, and tailor treatments to genetic profiles, thus improving efficacy and reducing adverse effects. In oncology, for instance, AI is helping identify actionable mutations and optimize targeted therapies, bringing more precise interventions to patients.
Beyond diagnosis and treatment, AI also plays a crucial role in accelerating drug discovery and development in precision medicine. Machine learning models can predict drug-target interactions, simulate clinical outcomes, and identify suitable patient cohorts for clinical trials, significantly cutting down timelines and costs. Moreover, AI enhances real-time monitoring of patient health through integration with digital health tools, facilitating timely interventions and adaptive treatment strategies. As data grows more complex and voluminous, AI's ability to synthesize, learn, and adapt offers an indispensable advantage in realizing the full potential of precision medicine.AI in Precision Medicine Market Insights
North America held the largest share of the AI in precision medicine market from 2025 to 2032. This leading position can be attributed to several key factors, including the increasing prevalence of chronic conditions such as cancer, lifestyle-related illnesses like diabetes, and various infectious diseases. The region also benefits from robust R&D initiatives in AI-driven precision medicine, a well-developed healthcare infrastructure.
In addition, major companies in the region are making substantial R&D investments to bring cutting-edge AI-based precision medicine solutions to market. For instance, in April 2024, Prenosis secured FDA De Novo marketing authorization for its Sepsis ImmunoScore™, an AI-powered diagnostic tool that supports precision diagnosis and risk assessment for sepsis. Likewise, in February 2025, Ibex Medical Analytics received FDA 510(k) clearance for Ibex Prostate Detect, an AI-enabled in vitro diagnostic device that generates heatmaps to detect small or rare prostatic cancers, offering a critical diagnostic aid for pathologists.
As a result of these combined factors, the AI in precision medicine market is expected to experience significant growth in North America throughout the forecast period.
To know more about why North America is leading the market growth in the AI in precision medicine market, get a snapshot of the AI in Precision Medicine Market Outlook
AI in Precision Medicine Market Dynamics
The AI in precision medicine market is undergoing rapid transformation, driven by the convergence of big data analytics, machine learning, and personalized healthcare. Precision medicine focuses on tailoring medical treatment to the individual characteristics of each patient, and AI enables this by analyzing vast datasets from genomic information to electronic health records to identify patterns, predict outcomes, and guide clinical decisions. This has created significant demand for AI-enabled platforms that can support drug discovery, diagnostics, and treatment planning, especially in oncology, rare diseases, and chronic conditions.
Market growth is being accelerated by increasing investments from pharmaceutical companies, biotech startups, and technology giants. These players are leveraging AI to reduce the cost and time of clinical trials, improve target identification, and develop more precise biomarkers. Government initiatives like the U.S. Precision Medicine Initiative and the EU's Digital Health Strategy are also catalyzing adoption by funding R&D and creating regulatory frameworks that support innovation in AI-driven healthcare solutions. As a result, the global market for AI in precision medicine is projected to grow at a strong CAGR through the next decade.
Despite these tailwinds, the market faces several challenges. Data privacy and interoperability remain major hurdles, especially given the sensitive nature of health data and the lack of standardized health IT systems across countries and institutions. Moreover, ethical concerns around algorithmic bias, transparency, and patient consent are prompting calls for tighter regulation and governance. Trust in AI systems remains a key barrier to adoption among healthcare professionals, who often require explainable and clinically validated outputs before integrating AI into routine practice.
Nevertheless, the competitive landscape is vibrant. Major tech firms are partnering with hospitals and research institutions to advance AI-driven care models. Startups focusing on niche applications, such as AI-powered pathology, genomic interpretation, and personalized oncology treatments, are also attracting significant venture capital. As the ecosystem matures, we can expect increasing consolidation and the emergence of integrated platforms that bridge diagnostics, therapeutics, and decision support, further driving market expansion.
Get a sneak peek at the AI in precision medicine market dynamics @ AI in Precision Medicine Market Dynamic Analysis
Report Metrics
Details
Coverage
Global
Study Period
2022–2032
AI in Precision Medicine Market CAGR
~33%
AI in Precision Medicine Market Size by 2032
USD 10.2 Billion
Key AI in Precision Medicine Companies
TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., among others
AI in Precision Medicine Market Assessment
AI in Precision Medicine Market Segmentation
AI in Precision Medicine Market Segmentation By Product: Hardware/Software and Services
AI in Precision Medicine Market Segmentation By Technology: Deep Learning, Natural Language Processing, and Machine Learning
AI in Precision Medicine Market Segmentation By Application: Drug Discovery & Development and Disease Diagnostics
AI in Precision Medicine Market Segmentation By Therapeutic Area: Oncology, Cardiology, Neurology, Infectious Disease, Immunology, and Others
AI in Precision Medicine Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the AI in precision medicine market are set to emerge as the trendsetter explore @ AI in Precision Medicine Companies
Table of Contents
1
AI in Precision Medicine Market Report Introduction
2
AI in Precision Medicine Market Executive Summary
3
Competitive Landscape
4
Regulatory Analysis
5
AI in Precision Medicine Market Key Factors Analysis
6
AI in Precision Medicine Market Porter's Five Forces Analysis
7
AI in Precision Medicine Market Layout
8
AI in Precision Medicine Market Company and Product Profiles
9
KOL Views
10
Project Approach
11
About DelveInsight
12
Disclaimer & Contact Us
Interested in knowing the AI in precision medicine market by 2032? Click to get a snapshot of the AI in Precision Medicine Market Trends
Related Reports
Artificial Intelligence in Drug Commercialization Market
Artificial Intelligence in Drug Commercialization Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in drug commercialization companies, including EVERSANA, Lyfegen, Syneos Health, McKinsey & Company, ICON plc., Clarivate., Thermo Fisher Scientific Inc., Viseven, ZS Associates, Cloud Pharmaceuticals Inc., among others.
Artificial Intelligence in Clinical Trials Market
Artificial Intelligence in Clinical Trials Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in clinical trials companies, including TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, among others.
Artificial Intelligence In Drug Discovery Market
Artificial Intelligence In Drug Discovery Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in drug discovery companies, including IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, among others.
Artificial Intelligence in Medical Imaging Market
Artificial Intelligence in Medical Imaging Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in medical imaging companies, including Microsoft, Siemens Healthineers, GE Healthcare, NVIDIA Corporation, Philips Healthcare, Arterys, Butterfly Network, Enlitic, HeartFlow, Digital Diagnostics, among others.
Artificial Intelligence in Life Sciences Market
Artificial Intelligence in Life Sciences Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in life sciences companies, including IBM Corporation, Atomwise, Inc., Nuance Communications, Inc., NuMedii, Inc., AiCure LLC, APIXIO, Inc., Insilico Medicine, Inc., Enlitic, Inc., Sensely, Inc., Zebra Medical Vision, among others.
DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Pipeline Assessment
Healthcare Licensing Services
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
CONTACT: Contact Us Shruti Thakur info@delveinsight.com +14699457679 https://www.delveinsight.com/medical-devicesSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
The Crisis of Care: Caily Confronts Caregiver Burnout with Launch of Comprehensive Digital Platform in Summer 2025
Denver, CO, June 02, 2025 (GLOBE NEWSWIRE) -- As caregiver burnout reaches unprecedented levels across the United States, a new health tech startup, Caily, is stepping forward to address what experts are calling a growing public health emergency. The Denver-based company has announced the upcoming launch of its integrated caregiver app, designed to provide comprehensive caregiver support across social, medical, legal, and emotional needs. Caily is the caregiving app for sharedcalendars, daily check-ins, health records, medication reminders, last wishes planning and more. With more than 53 million unpaid caregivers in the U.S., many of whom provide daily assistance to aging family members, disabled individuals, or chronically ill loved ones, the demands placed on these caregivers are staggering. Yet, despite their vital role, caregivers often go unrecognized in the broader healthcare and technology ecosystems. Caily's soon-to-launch digital platform aims to meet this need head-on by offering a unified system that improves coordination, communication, and overall care delivery. Unpacking the Caregiver Burnout Crisis Caregiving can be a rewarding act of compassion, but it is frequently accompanied by immense emotional, physical, and financial stress. The weight of daily caregiving responsibilities, often taken on with little formal training or institutional support, can lead to profound health consequences. Research from AARP notes that unpaid caregivers contribute nearly $600 billion worth of services annually, often while facing higher risks of depression, anxiety, and work-related stress. "Caregiver burnout isn't just an individual problem; it's a systemic issue with ripple effects across families, workplaces, and healthcare institutions," said Wynter Johnson, President & Co-Founder at Caily. "We built Caily specifically for caregivers, to offer the kind of centralized, accessible support that's been missing from their lives for far too long." A New Kind of Caregiver App Launching in Summer 2025, Caily introduces a new standard for caregiver support through a platform that unites care coordination in one easy-to-use interface. Accessible via desktop, iOS, Android, and tablet devices, the app allows caregivers to organize all aspects of care in a shared space. By bringing together the entire 'Care Circle,' consisting of family members and friends, Caily fosters better collaboration and reduces communication gaps that often lead to stress and mistakes. Designed in response to feedback from real caregiving communities, the app includes features such as daily check-ins, last-wishes planning, secure document storage, messaging tools, and health tracking. Whether managing medications, keeping up with legal documents, or simply coordinating who will accompany a loved one to a doctor's appointment, caregivers can rely on the platform to simplify their responsibilities. "The value of Caily lies in its specificity; this isn't a generic productivity app being repurposed," added Johnson. "It's a caregiver app, built from the ground up with the caregiver experience at its core." Caregiver Support Backed by Research Caily's development process was informed by extensive research and user testing. Throughout the design phase, the team engaged directly with caregivers to identify the common pain points that often lead to burnout. Among the most common challenges was feeling overwhelmed by a lack of clear communication and confusion around roles and responsibilities among those involved in caregiving. 'Caily gives caregivers the help they deserve and allows our loved ones to remain at the center of their own lives. Caily exists so that no one ever has to navigate this journey alone,' said McKenna McCormick, Caily Vice President & Co-Founder. Caily addresses these issues by offering a centralized communication hub that makes it easy to delegate tasks, update care plans, and ensure all stakeholders remain informed. This level of coordination not only lightens the caregiver's load but also leads to better outcomes for care receivers. According to content from Caily's blog, symptoms of caregiver burnout often go unrecognized until they escalate into serious health concerns. These include chronic fatigue, irritability, withdrawal from social activities, and even physical illness. Proactively providing tools for support can be a critical intervention. Launch Timeline and Waitlist The official launch of the Caily platform is scheduled for Summer 2025. In the lead-up to launch, interested users are encouraged to sign up for early access at Those who join the waitlist will receive priority access and updates on the platform's rollout. Caily is also continuing to gather feedback from family and professional caregivers, individuals who have received care, and support organizations in preparation for launch, with a goal to make the app as inclusive and adaptable as possible. About Caily Caily is a Denver-based health technology company focused on supporting caregivers through intuitive, coordinated solutions. By addressing the critical gaps in caregiver support, the company seeks to empower those who provide care with the resources, tools, and networks they need to thrive. Caily's mission is grounded in compassion, usability, and a commitment to improving the caregiving experience for everyone is the caregiving app that keeps everyone connected. CONTACT: Media Contact Company Name: Caily Contact Person: Jon Forisha Email: Country: United States Website:
Yahoo
2 hours ago
- Yahoo
The Crisis of Care: Caily Confronts Caregiver Burnout with Launch of Comprehensive Digital Platform in Summer 2025
Denver, CO, June 02, 2025 (GLOBE NEWSWIRE) -- As caregiver burnout reaches unprecedented levels across the United States, a new health tech startup, Caily, is stepping forward to address what experts are calling a growing public health emergency. The Denver-based company has announced the upcoming launch of its integrated caregiver app, designed to provide comprehensive caregiver support across social, medical, legal, and emotional needs. Caily is the caregiving app for sharedcalendars, daily check-ins, health records, medication reminders, last wishes planning and more. With more than 53 million unpaid caregivers in the U.S., many of whom provide daily assistance to aging family members, disabled individuals, or chronically ill loved ones, the demands placed on these caregivers are staggering. Yet, despite their vital role, caregivers often go unrecognized in the broader healthcare and technology ecosystems. Caily's soon-to-launch digital platform aims to meet this need head-on by offering a unified system that improves coordination, communication, and overall care delivery. Unpacking the Caregiver Burnout Crisis Caregiving can be a rewarding act of compassion, but it is frequently accompanied by immense emotional, physical, and financial stress. The weight of daily caregiving responsibilities, often taken on with little formal training or institutional support, can lead to profound health consequences. Research from AARP notes that unpaid caregivers contribute nearly $600 billion worth of services annually, often while facing higher risks of depression, anxiety, and work-related stress. "Caregiver burnout isn't just an individual problem; it's a systemic issue with ripple effects across families, workplaces, and healthcare institutions," said Wynter Johnson, President & Co-Founder at Caily. "We built Caily specifically for caregivers, to offer the kind of centralized, accessible support that's been missing from their lives for far too long." A New Kind of Caregiver App Launching in Summer 2025, Caily introduces a new standard for caregiver support through a platform that unites care coordination in one easy-to-use interface. Accessible via desktop, iOS, Android, and tablet devices, the app allows caregivers to organize all aspects of care in a shared space. By bringing together the entire 'Care Circle,' consisting of family members and friends, Caily fosters better collaboration and reduces communication gaps that often lead to stress and mistakes. Designed in response to feedback from real caregiving communities, the app includes features such as daily check-ins, last-wishes planning, secure document storage, messaging tools, and health tracking. Whether managing medications, keeping up with legal documents, or simply coordinating who will accompany a loved one to a doctor's appointment, caregivers can rely on the platform to simplify their responsibilities. "The value of Caily lies in its specificity; this isn't a generic productivity app being repurposed," added Johnson. "It's a caregiver app, built from the ground up with the caregiver experience at its core." Caregiver Support Backed by Research Caily's development process was informed by extensive research and user testing. Throughout the design phase, the team engaged directly with caregivers to identify the common pain points that often lead to burnout. Among the most common challenges was feeling overwhelmed by a lack of clear communication and confusion around roles and responsibilities among those involved in caregiving. 'Caily gives caregivers the help they deserve and allows our loved ones to remain at the center of their own lives. Caily exists so that no one ever has to navigate this journey alone,' said McKenna McCormick, Caily Vice President & Co-Founder. Caily addresses these issues by offering a centralized communication hub that makes it easy to delegate tasks, update care plans, and ensure all stakeholders remain informed. This level of coordination not only lightens the caregiver's load but also leads to better outcomes for care receivers. According to content from Caily's blog, symptoms of caregiver burnout often go unrecognized until they escalate into serious health concerns. These include chronic fatigue, irritability, withdrawal from social activities, and even physical illness. Proactively providing tools for support can be a critical intervention. Launch Timeline and Waitlist The official launch of the Caily platform is scheduled for Summer 2025. In the lead-up to launch, interested users are encouraged to sign up for early access at Those who join the waitlist will receive priority access and updates on the platform's rollout. Caily is also continuing to gather feedback from family and professional caregivers, individuals who have received care, and support organizations in preparation for launch, with a goal to make the app as inclusive and adaptable as possible. About Caily Caily is a Denver-based health technology company focused on supporting caregivers through intuitive, coordinated solutions. By addressing the critical gaps in caregiver support, the company seeks to empower those who provide care with the resources, tools, and networks they need to thrive. Caily's mission is grounded in compassion, usability, and a commitment to improving the caregiving experience for everyone is the caregiving app that keeps everyone connected. CONTACT: Media Contact Company Name: Caily Contact Person: Jon Forisha Email: Country: United States Website:
Yahoo
5 hours ago
- Yahoo
Extendicare Acquires Nine Long-Term Care Homes from Revera
MARKHAM, Ontario, June 02, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. ('Extendicare') (TSX: announced today that, effective June 1, 2025, it has completed the previously announced transaction with Revera Inc. and certain of its affiliates to acquire nine 'Class C' long-term care homes (the 'Acquired Homes') located in Ontario and Manitoba and one parcel of vacant land located in Ontario (the 'Transaction'). The consideration for the Transaction was approximately $60.3 million, comprised of $40.2 million in cash and the assumption of certain liabilities of $20.1 million, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand. The Acquired Homes are set out in the table below. Name Address LTC Beds(1) Retirement Beds Blenheim Community Village Blenheim, ON 57 30 Brierwood Gardens Brantford, ON 67 71 Riverbend Place Cambridge, ON 39 92 Summit Place Owen Sound, ON 99 77 Telfer Place Paris, ON 35 180 Village on the Ridge Ridgetown, ON 30 65 Trillium Court Kincardine, ON 34 59 Carlingview Manor(2) Ottawa, ON 250 – Poseidon Winnipeg, MB 211 – Total beds 822 574 (1) LTC beds excludes 133 third and fourth ward-style beds that have been taken out of service per regulatory requirements that are eligible to be reinstated upon redevelopment. (2) Carlingview Manor is in the process of being redeveloped into a new 320-bed LTC home that is owned by the joint venture between Extendicare and Axium. About Extendicare Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of a growing seniors' population, inspired by our mission to provide people with the care they need, wherever they call home. We operate a network of 99 long-term care homes (59 owned, 40 under management contracts), deliver approximately 11.2 million hours of home health care services annually, and provide group purchasing services to third parties representing approximately 148,200 beds across Canada. Extendicare proudly employs approximately 26,500 qualified, highly trained and dedicated team members who are passionate about providing high-quality care and services to help people live better. For further information, please contact: Investor Inquiries: David BaconExecutive Vice President and Chief Financial OfficerEmail: Phone: (905) 470-4000Sign in to access your portfolio
